Touchlight completes expansion, creating one of the world’s largest DNA manufacturing facilities in London, UK
- Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines.
- Transformation of Grade II-listed Victorian waterworks on the River Thames in Hampton, London.
- Supplying many of the top biopharmaceutical companies in the world to dramatically enhance their ability to develop genetic medicines.
- Expansion follows recent acceptance of a Drug Master File and first investigational new drug application using doggybone DNA.
Hampton, UK, 24 May 2023 – Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine treatments, has completed the redevelopment and expansion of its UK manufacturing facility, housed in a repurposed Victorian waterworks on the banks of the River Thames.